Phase II Evaluation of a High-Dose Mitoxantrone Based Induction Regimen in Untreated Adults with Acute Myeloid Leukemia

Eric J. Feldman New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York

Karen Seiter New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York

Frank Traganos New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York

Zbigniew Darzynkiewicz New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York

Heather Goff New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York

Monica Pozzuoli New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York

Paul Baskind New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York

Sarah Santos New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York

Tauseef Ahmed New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York

Your download is now in progress and you may close this window